We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Beta-blockers did not improve clinical outcomes after ...

A major analysis led by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), in collaboration with international institutions, has pooled data from 17,801 myocardial infarction survivors ...

The findings confirm the results of the CNIC-led REBOOT clinical trial and consolidate a paradigm shift in infarction treatment. A major analysis led by the Centro Nacional de Investigaciones ...

While building a simpler model for particle interactions, scientists made a sleek new pi. Representations of pi help scientists use values close to real life without storing a million digits. The ...

Madrid, Spain – 30 August 2025 : Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality, new myocardial infarction (MI) and heart failure (HF) compared with no ...

This is the first in our four-part series on beta cell function and why it matters for detecting type 1 diabetes early. For people at risk for type 1 diabetes, assessing beta cells, which produce ...

A panelist discusses how type 1 diabetes (T1D) is a complex autoimmune disease characterized by progressive beta cell destruction that advances through distinct stages, with genetic predisposition, ...

A groundbreaking study led by researchers at the Masonic Medical Research Institute (MMRI) has identified a promising molecular target to protect the heart against damage caused by a high-fat diet and ...

The microblogging platform Bluesky announced this week an important new feature for its users – Trending Topics. With the update, people can see what everyone is talking about on Bluesky. However, the ...

TIXiMED is developing TIX100, a proprietary non-immunosuppressive therapy that may become the first oral disease-modifying treatment option for people with type 1 diabetes The first-in-human, single ...

Recently, there has been ongoing dialogue with clinical researchers about the practical benefits of in-silico mathematical modelling in studying glucose metabolism. In fact, several in-silico models ...